Role of Genotyping in Non-Small Cell Lung Cancer Treatment: Current Status

Author： Bonanno Laura   Favaretto Adolfo   Rugge Massimo   Taron Miquel   Rosell Rafael  

Publisher： Adis International

ISSN： 0012-6667

Source： Drugs, Vol.71, Iss.17, 2011-12, pp. : 2231-2246

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pemetrexed for the treatment of non-small cell lung cancer

By Genova Carlo  

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 11, 2013-08 ,pp. : 1545-1558

Informa Healthcare

Access to resources Recommend Favorite

Vinorelbine in the Treatment of Non-Small Cell Lung Cancer

By  

Current Medicinal Chemistry, Vol. 9, Iss. 8, 2002-04 ,pp. : 879-891

Bentham Science Publishers

Access to resources Recommend Favorite

Neoadjuvant chemotherapy and chemoradiotherapy for non-small cell lung cancer: current status and future prospects

By Edelman Martin J  

Expert Opinion on Pharmacotherapy, Vol. 4, Iss. 6, 2003-06 ,pp. : 843-852

Informa Healthcare

Access to resources Recommend Favorite

MicroRNAs in Non-small Cell Lung Cancer: Current Status and Future Therapeutic Promises

By  

Current Pharmaceutical Design, Vol. 20, Iss. 24, 2014-05 ,pp. : 3982-3990

Bentham Science Publishers

Access to resources Recommend Favorite

FHIT and p53 Status and Response to Platinum-Based Treatment in Advanced Non-Small Cell Lung Cancer

By  

Current Cancer Drug Targets, Vol. 8, Iss. 5, 2008-08 ,pp. : 342-348

Bentham Science Publishers

Access to resources Recommend Favorite